Subscribe to Updates
Get the latest markets and assets news and updates directly to your inbox.
Pfizer won its fight to buy an obesity-drug maker. It took an extra $1.7 billion and a phone call.
Keep Reading
© 2025 The Asset Observer. All Rights Reserved.
